HSBC Holdings’s Amylyx Pharmaceuticals AMLX Stock Holding History

HSBC Holdings’s Portfolio AMLX Stock Details AMLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$157K	Buy	+11,414	New	+$161K	﹤0.01%	2671
2025 Q4	–	Sell	-19,369	Closed	-$278K	–	2919
2025 Q3	$278K	Buy	+19,369	New	+$182K	﹤0.01%	2358
2025 Q2	–	Sell	-14,419	Closed	-$51.4K	–	3017
2025 Q1	$51.4K	Buy	14,419 +2,853	+25%	+$10.2K	﹤0.01%	2901
2024 Q4	$43.3K	Sell	11,566 -50,121	-81%	-$236K	﹤0.01%	3008
2024 Q3	$197K	Sell	61,687 -14,574	-19%	-$32.8K	﹤0.01%	2620
2024 Q2	$150K	Buy	76,261 +27,954	+58%	+$54.2K	﹤0.01%	2644
2024 Q1	$137K	Buy	+48,307	New	+$632K	﹤0.01%	2774

Other funds holding AMLX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

SVCM

Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

HSBC Holdings's AMLX Position: Q1 2026 in Review

HSBC Holdings opened a new position in Amylyx Pharmaceuticals (AMLX) in Q1 2026: 11,414 shares worth $157K. The stake represents ﹤0.01% of the portfolio and ranks #2671 among its holdings. This is a return to the name: HSBC Holdings previously reported a position in AMLX as recently as Q3 2025.

HSBC Holdings first reported a position in AMLX in Q1 2024 and has held it in 7 quarters since. The position peaked at $278K in Q3 2025. 171 funds tracked by Wall St. Rank hold AMLX as of Q1 2026.

HSBC Holdings held 11,414 shares of Amylyx Pharmaceuticals worth $157K as of Q1 2026.
Amylyx Pharmaceuticals was a new HSBC Holdings position in Q1 2026.
Amylyx Pharmaceuticals made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #2671 holding.
HSBC Holdings first reported a position in Amylyx Pharmaceuticals in Q1 2024 and has held it in 7 quarters since.
HSBC Holdings's Amylyx Pharmaceuticals position peaked at $278K in Q3 2025.
171 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.